XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Operating activities    
Net income $ 24,096 $ 18,483
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 5,305 5,241
Deferred income taxes 11 5,485
Provision for credit losses, doubtful accounts receivable, and reserve for settlement assets 929 1,002
Stock-based compensation 2,015 912
Other 1,449 692
Changes in assets and liabilities:    
Trade accounts receivable 1,270 689
Settlement assets, disbursement prefunding, prepaid expenses, other current assets, and other assets (56,416) (21,269)
Trade accounts payable, accrued expenses, settlement liabilities, other current liabilities, and other liabilities (350) (12,771)
Customer funds deposits 10,608 2,810
Deferred revenue 944 (1,110)
Net cash (used in) provided by operating activities (10,139) 164
Investing activities    
Capital expenditures (5,821) (5,278)
Purchase of convertible preferred stock in equity method investment (673)
Purchases of debt securities and equity investments (16,061) (12,669)
Proceeds from maturities and sales of debt securities and redemption of equity investments 12,684 9,878
Net cash used in investing activities (9,198) (8,742)
Financing activities    
Dividends paid (1,514) (1,261)
Distributions to noncontrolling interests (50)
Proceeds from borrowings under revolving credit facility 12,713 14,243
Repayment of borrowings under revolving credit facility (12,713) (14,243)
Repurchases of Class B common stock (7,604) (2,432)
Net cash used in financing activities (9,168) (3,693)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash and cash equivalents (160) 28
Net decrease in cash, cash equivalents, and restricted cash and cash equivalents (28,665) (12,243)
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period 341,832 255,456
Cash, cash equivalents, and restricted cash and cash equivalents at end of period 313,167 243,213
Supplemental Schedule of Non-Cash Financing Activities    
Shares of the Company’s Class B common stock issued to an executive officer for bonus payment $ 1,824